Active proliferation of different cell types, including lymphocytes, in human atherosclerotic plaques
- PMID: 7677178
- PMCID: PMC1870963
Active proliferation of different cell types, including lymphocytes, in human atherosclerotic plaques
Abstract
Cell proliferation, an important mechanism of atherosclerotic plaque growth, occurs among smooth muscle, inflammatory cell, and other cell types. We have identified different topographical patterns of cell proliferation in human carotid plaques, based on cell type. Cell proliferation was determined with an antibody to the proliferating cell nuclear antigen (PCNA), combined with cell type-specific antibodies. Despite low levels of overall proliferative activity, the intima displayed more proliferative activity than the underlying media (1.61 +/- 0.35% in intima versus 0.05 +/- 0.03% in media; P < 0.01). The preponderant proliferative cell type in the intima was the monocyte/macrophage (46.0% of PCNA-positive cells), with a minority being smooth muscle alpha-actin-positive (9.7%), microvascular endothelial (14.3%), and T cells (13.1%). Smooth muscle cells were the dominant proliferating cell type in the media (44.4% of PCNA-positive cells versus 20% endothelial cells, 13.0% monocyte/macrophages, and 14.3% T cells). Within the plaque, foam-cell-rich regions mostly displayed proliferation among macrophages (66.5%), whereas in vascularized fields PCNA positivity was almost equally shared by endothelial cells (23.8%), monocyte/macrophages (26.3%), smooth muscle alpha-actin-positive cells (14.0%), and to a lesser extent, T cells (8.2%). Logistic and linear regression analyses also demonstrated that location in foam-cell-rich regions was a significant predictor of proliferation only among monocyte/macrophages, whereas location in vascularized regions was a good predictor of PCNA positivity among both inflammatory and noninflammatory cells. These different patterns of cell type proliferation suggest possibly different distributions of putative responsible growth regulatory factors in human atherosclerosis.
Similar articles
-
Human atherosclerosis. IV. Immunocytochemical analysis of cell activation and proliferation in lesions of young adults.Am J Pathol. 1993 Jun;142(6):1787-93. Am J Pathol. 1993. PMID: 8099470 Free PMC article.
-
The histologic characteristics of primary and restenotic carotid plaque.J Surg Res. 1998 Jan;74(1):27-33. doi: 10.1006/jsre.1997.5222. J Surg Res. 1998. PMID: 9536969
-
[Numbers of cells and cell proliferation in intima of different human arteries].Tsitologiia. 2011;53(10):815-25. Tsitologiia. 2011. PMID: 22232939 Russian.
-
Fibrous cap formation or destruction--the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation.Cardiovasc Res. 1999 Feb;41(2):345-60. Cardiovasc Res. 1999. PMID: 10341834 Review.
-
Atherogenesis and inflammation.Eur Heart J. 1993 Dec;14 Suppl K:2-6. Eur Heart J. 1993. PMID: 8131783 Review.
Cited by
-
Human coronary heart disease: importance of blood cellular miR-2909 RNomics.Mol Cell Biochem. 2014 Jul;392(1-2):49-63. doi: 10.1007/s11010-014-2017-3. Epub 2014 Mar 16. Mol Cell Biochem. 2014. PMID: 24634009
-
The role of costimulatory receptors of the tumour necrosis factor receptor family in atherosclerosis.J Biomed Biotechnol. 2012;2012:464532. doi: 10.1155/2012/464532. Epub 2011 Dec 22. J Biomed Biotechnol. 2012. PMID: 22235167 Free PMC article. Review.
-
Sphingosine kinase regulates oxidized low density lipoprotein-mediated calcium oscillations and macrophage survival.J Lipid Res. 2010 May;51(5):991-8. doi: 10.1194/jlr.M000398. Epub 2009 Nov 5. J Lipid Res. 2010. PMID: 19965613 Free PMC article.
-
Cellular phenotypes in human stenotic lesions from haemodialysis vascular access.Nephrol Dial Transplant. 2009 Sep;24(9):2786-91. doi: 10.1093/ndt/gfn708. Epub 2009 Apr 17. Nephrol Dial Transplant. 2009. PMID: 19377054 Free PMC article.
-
Aortic endothelial cells regulate proliferation of human monocytes in vitro via a mechanism synergistic with macrophage colony-stimulating factor. Convergence at the cyclin E/p27(Kip1) regulatory checkpoint.J Clin Invest. 1997 Jun 15;99(12):2867-76. doi: 10.1172/JCI119480. J Clin Invest. 1997. PMID: 9185509 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous